Business classification

VCID: 416596
    Profile

    Corporate information

    Official name
    Vivo Capital LLC

    Registration country
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Ajax Therapeutics Inc
    Blood cancer biotech.
    United States 13 May 2024 Series C
    Initial investment. Round participant. Active
    Blossomhill Therapeutics Inc
    Biotechnology company focused on oncology and autoimmune disorders.
    United States 4 Mar 2021 Series A
    Initial investment. Round participant. Active
    Poseida Therapeutics Inc
    United States 3 Apr 2018
    22 Apr 2019
    Series C
    Round participant. Active
    Tricida Inc
    United Kingdom 15 Jul 2016 Series C
    Led the investment round. Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.